Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1359-1364

  Canbay, Emel ^a   Agachan, Bedia ^b   Gulluoglu, Mine ^c   Isbir, Turgay ^b   Balik, Emre ^c   Yamaner, Sumer ^c   Bulut, Turker ^c   Cacina, Canan ^b   Eraltan, Ilhan Yaylim ^b   Yilmaz, Aytul ^c   Bugra, Dursun ^c  

^a Basaksehir State Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

DNA repair genes; Gastric cancer; Polymorphism

Indexed keywords

APYRIMIDINE ENDONUCLEASE 1; DNA GLYCOSYLTRANSFERASE; HOGG1 PROTEIN; SERINE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XERODERMA PIGMENTOSUM GROUP G PROTEIN; XRCC1 PROTEIN; XRCC3 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; DNA GLYCOSYLASES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; ENDONUCLEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 77953772492     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 5: 225-249, 2009.
2. Kushi LH, Byers T, Doyle C, Bandera EV, McCullough M, McTiernan A, Gansler T, Andrews KS and Thun MJ: American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 56: 254-281, 2006.
3. Masuda G, Tokunaga A, Shirakawa T, Togashi A, Kiyama T, Kato S, Matsukura N, Bou H, Watanabe M and Tajiri T: Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years. Gastric Cancer 10: 98-103, 2007.
4. Yasui W, Oue N, Kitadai Y and Nakayama H: Recent advances in molecular pathobiology of gastric carcinoma. In: The Diversity of Gastric Carcinoma. Kaminishi M, Takubo K and Mafune K. (eds). Tokyo Springer-Verlag, pp. 51-71, 2005.
5. González CA, Sala N and Capellá G: Genetic susceptibility and gastric cancer risk. Int J Cancer 100: 249-260, 2002.
6. Wood RD, Mitchell M, Sgouros J and Lindahl T: Human DNA repair genes. Science 291: 1284-1289, 2001.
7. Oliver FJ, Menissier-de Murcia J and de Murcia G: Poly (ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 64:1282-1288,1999.
8. Thompson LH and West MG: XRCC1 keeps DNA from getting stranded. Mutat Res 459: 1-18, 2000.
9. Sancar A and Tang MS: Nucleotide excision repair. Photochem Photobiol 57: 905-921, 1993.
10. Neumann AS, Sturgis EM and Wei Q: Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 42: 65-92, 2005.
11. Arbault S, Sojic N, Bruce D, Amatore C, Sarasin A and Vuillaume M: Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis 25: 509-515, 2004.
12. Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR and Albanes D: Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 191: 171-178, 2003.
13. Kanaar R, Hoeijmakers JH and van Gent DC: Molecular mechanisms of DNA double-strand break repair. Trends Cell Biol 8: 483-489, 1998.
14. Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, Wojnarowska F and Welsh KI: A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60: 5612-5616, 2000.
15. Poplawski T, Arabski M, Kozirowska D, Blasinska-Morawiec M, Morawiec Z, Morawiec-Bajda A, Klupinska G, Jeziorski A, Chojnacki J and Blasiak J: DNA damage and repair in gastric cancer - a correlation with the hOGG1 and RAD51 gene polymorphisms. Mutat Res 601: 83-91,2006.
16. Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, Dong ZW, Dawsey SM, Mark SD and Taylor PR: Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett 216: 157-164, 2004.
17. Lee SG, Kim B, Choi J, Kim C, Lee I and Song K: Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett 187: 53-60, 2002.
18. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, Wang X, Spitz MR and Wei Q: Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88: 601-606, 2000.
19. Ruzzo A, Canestrari E, Maltese P, Pizzagalli F, Graziano F, Santini D, Catalano V, Ficarelli R, Mari D, Bisonni R, Giordani P, Giustini L, Lippe P, Silva R, Mattioli R, Torresi U, Latini L and Magnani M: Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med 45: 822-828, 2007.
20. Sobin LH and Wittekind C: International Union Against Cancer (IUCC). TNM classification of malignant tumors, 5th ed. New York: John Wiley & Sons, 1997.
21. Miller SA, Dykes DD and Polesky HF: A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
22. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A and Case LD: Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22: 917-922, 2001.
23. Le Marchand L, Donlon T, Lum-Jones A, Seifried A and Wilkens LR: Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 11: 409-412, 2002.
24. Yeh CC, Sung FC, Tang R, Chang-Chieh CR and Hsieh LL: Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 28: 5-12, 2005.
25. Mort R, Mo L, McEwan C and Melton DW: Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 89: 333-337, 2003.
26. Wilson DM 3rd, and Bohr VA: The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst) 6: 544-559, 2007.
27. Parikh SS, Mol CD and Tainer JA: Base excision repair enzyme family portrait: integrating the structure and chemistry of an entire DNA repair pathway. Structure 5: 1543-1550, 1997.
28. Izumi T, Hazra TK, Boldogh I, Tomkinson AE, Park MS, Ikeda S and Mitra S: Requirement for human AP endonuclease 1 for repair of 3′-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogenesis 21: 1329-34, 2000.
29. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J and Koch M: Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme APE1/ref-1 in prostate cancer. Clin Cancer Res 7: 824-830, 2001.
30. Hadi MZ, Coleman MA, Fidelis K, Mohrenweiser HW and Wilson DM 3rd: Functional characterization of APE1 variants identified in the human population. Nucleic Acids Res 28: 3871-3879, 2000.
31. Au WW, Salama SA and Sierra-Torres CH: Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111: 1843-1850, 2003.
32. Gu D, Wang M, Wang M, Zhang Z and Chen J: The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies. Mutagenesis 24: 507-512, 2009.
33. Tsukino H, Hanaoka T, Otani T, Iwasaki M, Kobayashi M, Hara M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y and Tsugane S: hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci 95: 977-983, 2004.
34. Hanaoka T, Sugimura H, Nagura K, Ihara M, Li XJ, Hamada GS, Nishimoto I, Kowalski LP, Yokota J and Tsugane S: hOGG1 exon7 polymorphism and gastric cancer in case-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Lett 170: 53-61, 2001.
35. Capellá G, Pera G, Sala N, Agudo A, Rico F, Del Giudicce G, Plebani M, Palli D, Boeing H, Bueno-de-Mesquita HB, Carneiro F, Berrino F, Vineis P, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key T, Bingham S, Caldas C, Linseisen J, Nagel G, Overvad K, Tjonneland A, Boshuizen HC, Peeters PH, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund E, Jenab M, Kaaks R, Riboli E and González CA: DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol 37: 1316-1325, 2008.
36. Takezaki T, Gao CM, Wu JZ, Li ZY, Wang JD, Ding JH, Liu YT, Hu X, Xu TL, Tajima K and Sugimura H: hOGG1 Ser (326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 99: 624-627, 2002.
37. Shen H, Wang X, Hu Z, Zhang Z, Xu Y, Hu X, Guo J and Wei Q: Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population. Cancer Lett 206: 51-58, 2004.
38. Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D and Silva AE: Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol 42: 6593-6600, 2005.
39. Geng J, Zhang YW, Huang GC and Chen LB: XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. World J Gastroenterol 14: 6733-6737, 2008.
40. Wang N, Dong XJ, Zhou RM, Guo W, Zhang XJ and Li Y: An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol Biol Rep 36: 357-364, 2009.
41. Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, Zatonski W and Hayes RB: Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 26: 1354-1359, 2005.
42. Zárate RN, Arias F, Bandres E, Cubedo E, Malumbres R and García-Foncillas J: Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy. World J Gastroenterol 12: 6032-6036, 2006.
43. Kim MS, Yoo NJ and Lee SH: Frameshift mutation at mononucleotide repeat in ERCC5 in gastric carcinomas with microsatellite instability. Pathology 41: 394-395, 2009.